Ligand Pharmaceuticals Insider Sold Shares Worth $1,566,377, According to a Recent SEC Filing
Andrew Reardon, Chief Legal Officer & Secretary, on June 30, 2026, sold 5,000 shares in Ligand Pharmaceuticals (LGND) for $1,566,377. Following the Form 4 filing with the SEC, Reardon has control over a total of 41,514 common shares of the company, with 41,514 shares held directly. SEC Filing:
Andrew Reardon, Chief Legal Officer & Secretary, on June 30, 2026, sold 5,000 shares in Ligand Pharmaceuticals (LGND) for $1,566,377.
Following the Form 4 filing with the SEC, Reardon has control over a total of 41,514 common shares of the company, with 41,514 shares held directly.
SEC Filing: